NCT06508866 Timing And Typology of ConducTIon disturbanCes During TAVI
| NCT ID | NCT06508866 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Clinico Humanitas |
| Condition | Aortic Stenosis, Severe |
| Study Type | OBSERVATIONAL |
| Enrollment | 490 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 490 participants in total. It began in 2023-02-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The TACTIC-TAVI registry aims to collect information about a consecutive cohort of patients undergoing transcatheter aortic valve insertion. The registry is international, multi-centre and observational. The registry is planned to continue until the calculated sample size is achieved.
Eligibility Criteria
Inclusion Criteria: Patients successfully undergoing transcatheter aortic valve implantation for native severe aortic stenosis. \- Exclusion Criteria: 1. Presence of previously implanted permanent cardiac pacemaker. 2. Valve-in-valve procedures. 3. No pre-procedural electrocardiogram is available. 4. No pre-procedural contrast CT TAVI is available. 5. Enrollment in another clinical trial. 6. Patients aged less than 18 years old. 7. Patients who do not consent for their data to be included in the registry. 8. Failed transcatheter aortic valve deployment. -
Contact & Investigator
Antonio Mangieri, MD
PRINCIPAL INVESTIGATOR
Humanitas Research Horspital
Frequently Asked Questions
Who can join the NCT06508866 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Stenosis, Severe. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06508866 currently recruiting?
Yes, NCT06508866 is actively recruiting participants. Contact the research team at antonio.mangieri@humanitas.it for enrollment information.
Where is the NCT06508866 trial being conducted?
This trial is being conducted at Rozzano, Italy.
Who is sponsoring the NCT06508866 clinical trial?
NCT06508866 is sponsored by Istituto Clinico Humanitas. The principal investigator is Antonio Mangieri, MD at Humanitas Research Horspital. The trial plans to enroll 490 participants.